End-Stage Renal Disease (ESRD) Latest Advances

Effect of AST-120 treatment discontinuation and serum albumin on free and bound indoxyl sulphate in end-stage kidney disease.

Journal: International journal of clinical pharmacology and therapeutics

Published: January 16, 2026

Non-syndromic Multifocal Low-Grade Oncocytic Renal Tumors, Including Microtumors, in End-Stage Renal Disease Kidneys with Synchronous Non-TSC Renal Cell Neoplasms.

Journal: International journal of surgical pathology

Published: January 16, 2026

Response to comment on "Risk factors for incident or persistent SARC-F-defined sarcopenia in patients with end-stage kidney disease: a cohort study".

Journal: Journal of the Formosan Medical Association = Taiwan yi zhi

Published: January 14, 2026

Impact of Remnant Cholesterol on the Risk for End-Stage Renal Disease in Type 2 Diabetes Mellitus: A Nationwide Population-Based Cohort Study (Diabetes Metab J 2025;49:1106-15).

Journal: Diabetes & metabolism journal

Published: January 14, 2026

Impact of Remnant Cholesterol on the Risk for End-Stage Renal Disease in Type 2 Diabetes Mellitus: A Nationwide Population-Based Cohort Study (Diabetes Metab J 2025;49:1106-15).

Journal: Diabetes & metabolism journal

Published: January 14, 2026

Comment on "Risk factors for incident or persistent SARC-F-defined sarcopenia in patients with end-stage kidney disease: a cohort study".

Journal: Journal of the Formosan Medical Association = Taiwan yi zhi

Published: January 10, 2026

Kidney Replacement Therapy Sequences: Racial/Ethnic Disparities in End-Stage Kidney Disease Patients' 10-Year Treatment Histories.

Journal: Kidney medicine

Published: January 09, 2026

Peritoneal Dialysis Conversion as a Salvage Therapy for Refractory Intraocular Pressure Fluctuations During Hemodialysis in a Patient With End-Stage Kidney Disease.

Journal: Kidney medicine

Published: January 08, 2026

Laparoscopic-based renal sympathetic denervation for the management of refractory hypertension in patients with end-stage renal disease: A case series of three patients.

Journal: Clinical nephrology

Published: December 22, 2025

Dasatinib-Associated Recurrent Symptomatic Bilateral Pleural Effusions in an Elderly Patient With End-Stage Renal Disease on Maintenance Hemodialysis.

Journal: Cureus

Published: December 18, 2025

Hypoalbuminemia and Hospitalization Risk in Mexican Patients With End-Stage Renal Disease on Hemodialysis: A Single-Center, Retrospective, Cross-Sectional Study.

Journal: Cureus

Published: December 17, 2025

Uncertain benefit, certain harm: the anticoagulation paradox in hemodialysis-re-evaluation of stroke prevention and bleeding risk in end-stage kidney disease.

Journal: The Korean journal of internal medicine

Published: December 12, 2025

Filters

Effect of AST-120 treatment discontinuation and serum albumin on free and bound indoxyl sulphate in end-stage kidney disease.

Effect of AST-120 treatment discontinuation and serum albumin on free and bound indoxyl sulphate in end-stage kidney disease.

Non-syndromic Multifocal Low-Grade Oncocytic Renal Tumors, Including Microtumors, in End-Stage Renal Disease Kidneys with Synchronous Non-TSC Renal Cell Neoplasms.

Non-syndromic Multifocal Low-Grade Oncocytic Renal Tumors, Including Microtumors, in End-Stage Renal Disease Kidneys with Synchronous Non-TSC Renal Cell Neoplasms.

Response to comment on "Risk factors for incident or persistent SARC-F-defined sarcopenia in patients with end-stage kidney disease: a cohort study".

Response to comment on "Risk factors for incident or persistent SARC-F-defined sarcopenia in patients with end-stage kidney disease: a cohort study".

Impact of Remnant Cholesterol on the Risk for End-Stage Renal Disease in Type 2 Diabetes Mellitus: A Nationwide Population-Based Cohort Study (Diabetes Metab J 2025;49:1106-15).

Impact of Remnant Cholesterol on the Risk for End-Stage Renal Disease in Type 2 Diabetes Mellitus: A Nationwide Population-Based Cohort Study (Diabetes Metab J 2025;49:1106-15).

Impact of Remnant Cholesterol on the Risk for End-Stage Renal Disease in Type 2 Diabetes Mellitus: A Nationwide Population-Based Cohort Study (Diabetes Metab J 2025;49:1106-15).

Impact of Remnant Cholesterol on the Risk for End-Stage Renal Disease in Type 2 Diabetes Mellitus: A Nationwide Population-Based Cohort Study (Diabetes Metab J 2025;49:1106-15).

Comment on "Risk factors for incident or persistent SARC-F-defined sarcopenia in patients with end-stage kidney disease: a cohort study".

Comment on "Risk factors for incident or persistent SARC-F-defined sarcopenia in patients with end-stage kidney disease: a cohort study".

Kidney Replacement Therapy Sequences: Racial/Ethnic Disparities in End-Stage Kidney Disease Patients' 10-Year Treatment Histories.

Kidney Replacement Therapy Sequences: Racial/Ethnic Disparities in End-Stage Kidney Disease Patients' 10-Year Treatment Histories.

Peritoneal Dialysis Conversion as a Salvage Therapy for Refractory Intraocular Pressure Fluctuations During Hemodialysis in a Patient With End-Stage Kidney Disease.

Peritoneal Dialysis Conversion as a Salvage Therapy for Refractory Intraocular Pressure Fluctuations During Hemodialysis in a Patient With End-Stage Kidney Disease.

Laparoscopic-based renal sympathetic denervation for the management of refractory hypertension in patients with end-stage renal disease: A case series of three patients.

Laparoscopic-based renal sympathetic denervation for the management of refractory hypertension in patients with end-stage renal disease: A case series of three patients.

Dasatinib-Associated Recurrent Symptomatic Bilateral Pleural Effusions in an Elderly Patient With End-Stage Renal Disease on Maintenance Hemodialysis.

Dasatinib-Associated Recurrent Symptomatic Bilateral Pleural Effusions in an Elderly Patient With End-Stage Renal Disease on Maintenance Hemodialysis.

Hypoalbuminemia and Hospitalization Risk in Mexican Patients With End-Stage Renal Disease on Hemodialysis: A Single-Center, Retrospective, Cross-Sectional Study.

Hypoalbuminemia and Hospitalization Risk in Mexican Patients With End-Stage Renal Disease on Hemodialysis: A Single-Center, Retrospective, Cross-Sectional Study.

Uncertain benefit, certain harm: the anticoagulation paradox in hemodialysis-re-evaluation of stroke prevention and bleeding risk in end-stage kidney disease.

Uncertain benefit, certain harm: the anticoagulation paradox in hemodialysis-re-evaluation of stroke prevention and bleeding risk in end-stage kidney disease.